Concepedia

Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate

Kevin J. Ryan, Jennifer S. Guimbellot, Alexander E. Dowell, Kedria D. Reed-Walker, Corenna Kerstner-Wood, Justin D. Anderson, Zhongyu Liu, Edward P. Acosta

Journal of Chromatography B · 2022 · 20 citations · 18 references

DOIFull text

Open access

Concepts

References

18

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

, , +8

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek et al. · New England Journal of Medicine · 2019 · 2.1K citations · Full text

, , +16

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +15

Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy

Christopher N. Fortner, Julie M. Seguin, Denise M. Kay · Journal of Cystic Fibrosis · 2021 · 110 citations

, , +14

A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus

Sylvia Szentpetery, Kimberly Foil, Sara J. Hendrix et al. · Journal of Cystic Fibrosis · 2022 · 100 citations

, , +10